Safety and efficacy of the newly developed liquid type bowel cleansing agent for bowel preparation for colonoscopy (independent study)

Safety and efficacy of the newly developed liquid type bowel cleansing agent for bowel preparation for colonoscopy (independent study) - Safety and efficacy of theliquid type bowel cleansing agent

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007531

Enrollment

Registered

2012-03-19

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon tumor

Interventions

Patients who are planned to undergo colonoscopy intake SUPREP

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are planned to undergo colonoscopy with written IC

Exclusion criteria

Exclusion criteria: Bowel obstruction Bowel perforation Toxic megacolon Gastric outlet obstruction

Design outcomes

Primary

Measure	Time frame
Safety of SUPREP	—

Secondary

Measure	Time frame
Bowel cleansing efficacy of SUPREP	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026